These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6251761)

  • 41. Long-term converting enzyme inhibition and sympathetic nerve function in hypertensive humans.
    Zanella MT; Bravo EL; Fouad FM; Tarazi RC
    Hypertension; 1981; 3(6 Pt 2):II-216-21. PubMed ID: 6271671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
    Seedat YK
    S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of captopril on plasma prolactin in patients with essential hypertension.
    Saito I; Takeshita E; Hayashi S; Takenaka T; Murakami M; Saruta T; Nagano S; Sekihara T
    Angiology; 1990 May; 41(5):377-81. PubMed ID: 2192585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of blood-pressure lowering effect of captopril in anephric patients.
    Leslie BR; Case DB; Sullivan JF; Vaughan ED
    Br Med J; 1980 Apr; 280(6221):1067-8. PubMed ID: 6992919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Apr; 3(4):1035-43. PubMed ID: 6323565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Brunner HR; Gavras H; Waeber B; Kershaw GR; Turini GA; Vukovich RA; McKinstry DN; Gavras I
    Ann Intern Med; 1979 Jan; 90(1):19-23. PubMed ID: 217289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of angiotensin converting enzyme inhibition with captopril on blood pressure and adrenergic function in normal and sodium restricted rats.
    Sybertz EJ; Sabin CS; Moran R
    Clin Exp Hypertens (1978); 1981; 3(5):1053-73. PubMed ID: 6269812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion.
    Morganti JA; Pickering TG; Lopez-Ovejero JA; Laragh JH
    J Clin Endocrinol Metab; 1980 Apr; 50(4):748-54. PubMed ID: 6245101
    [No Abstract]   [Full Text] [Related]  

  • 49. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
    Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A
    J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.
    Man in 't Veld AJ; Schicht IM; Derkx FH; de Bruyn JH; Schalekamp MA
    Br Med J; 1980 Feb; 280(6210):288-90. PubMed ID: 6986949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical use of an orally acting converting enzyme inhibitor: captopril.
    Brunner HR; Gavras H; Waeber B; Textor SC; Turini GA; Wauters JP
    Hypertension; 1980; 2(4):558-66. PubMed ID: 6995296
    [No Abstract]   [Full Text] [Related]  

  • 52. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Captopril in the treatment of hypertension.
    Staessen J; Fagard R; Lijnen P; Amery A
    Acta Clin Belg; 1982; 37(3):164-84. PubMed ID: 6214916
    [No Abstract]   [Full Text] [Related]  

  • 54. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients.
    Rosenthal T; Holtzman E; Yaron A
    Clin Exp Hypertens A; 1982; 4(3):367-77. PubMed ID: 6280902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular reflexes during long-term converting enzyme inhibition and sodium depletion. The response to tilt in hypertensive patients.
    Cody RJ; Bravo EL; Fouad FM; Tarazi RC
    Am J Med; 1981 Sep; 71(3):422-6. PubMed ID: 7025621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors related to first dose hypotensive effect of captopril: prediction and treatment.
    Hodsman GP; Isles CG; Murray GD; Usherwood TP; Webb DJ; Robertson JI
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):832-4. PubMed ID: 6403103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
    Huang CM; del Greco F; Quintanilla A; Molteni A
    JAMA; 1981 Feb; 245(5):478-82. PubMed ID: 7005474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M; Delin K; Herlitz H
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of captopril on heart rate in several types of hypertensive patients.
    Imai Y; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1981 Feb; 133(2):243-4. PubMed ID: 7022748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The long term effects of the oral converting enzyme inhibitor, captopril in hypertensive patients--the endocrinological study of its hypotensive mechanism (author's transl)].
    Ogihara T; Maruyama A; Naka T; Hata T; Mikami H; Nakamaru M; Gotoh S; Masuo K; Otsuka A; Tsuchiya T; Tabuchi Y; Ohde H; Kumahara Y; Iwanaga K; Yanaihara C; Ohkaru H; Yanaihara N
    Nihon Naibunpi Gakkai Zasshi; 1980 Oct; 56(10):1484-96. PubMed ID: 6256218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.